Plasma allopregnanolone levels in drug-free, comorbidity-free obsessive-compulsive disorder

dc.contributor.authorInce, Lara Utku
dc.contributor.authorErbay, Lale Gonenir
dc.date.accessioned2019-07-19T07:49:38Z
dc.date.available2019-07-19T07:49:38Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: Although there are studies in the literature focusing on the relationship between neurosteroids and psychiatric disorders, the studies on patients with obsessive-compulsive disorder (OCD) are limited in number. Nevertheless, allopregnanolone, a neurosteroid, in OCD patients has not been investigated in this limited number of studies. Allopregnanolone is considered to have a role in the pathogenesis of many psychiatric disorders. Accordingly, the present study aimed to investigate the relationship between the neurosteroid allopregnanolone and OCD. Methods: The study included 40 OCD patients diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria and 40 healthy control subjects. The study participants completed the Yale-Brown Obsessive Compulsive Scale. Taking the diurnal rhythm of neurosteroids into consideration, blood samples for determination of plasma allopregnanolone levels were obtained from all patients and controls between 09: 00 and 10: 00 in the morning after 12 hours of fasting, tobacco abstinence, and 30 minutes of resting period. Plasma allopregnanolone level was analyzed using the enzyme-linked immunosorbent assay (ELISA). Results: No significant difference was determined between the patient and control groups regarding serum allopregnanolone levels. Evaluation of the allopregnanolone levels of the patients for each obsession type according to its presence and absence revealed no significant difference in any of them. Evaluation of the allopregnanolone levels of the patients for each compulsion type according to its presence and absence revealed that the allopregnanolone level of the patients with counting-organizing compulsive behavior was lower than that of those without. Discussion: Although there was no difference between OCD patients and controls regarding plasma allopregnanolone level, it is difficult to make a conclusion that allopregnanolone level does not play a role in the etiopathogenesis of disease. Conducting further studies, which would analyze allopregnanolone level in materials other than plasma such as cerebrospinal fluid using multiple analyses and separately evaluates females and males with higher number of patients, is of importance to enlighten at least some aspects of allopregnanolone-OCD relationship. Moreover, significantly lower plasma allopregnanolone level particularly in a single type of compulsion brings in mind again the suggestion that different etiopathogenesis might have a role in the symptom subtypes of OCD, which has begun to be discussed in the recent years.en_US
dc.identifier.citationInce, LU. Erbay, LG. (2018). Plasma allopregnanolone levels in drug-free, comorbidity-free obsessive-compulsive disorder. Cilt:19. Sayı:5. 435-442 ss.en_US
dc.identifier.doi10.5455/apd.283095en_US
dc.identifier.endpage442en_US
dc.identifier.issn1302-6631
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-85065198173en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage435en_US
dc.identifier.trdizinid286242en_US
dc.identifier.urihttps://doi.org/10.5455/apd.283095
dc.identifier.urihttps://hdl.handle.net/11616/12780
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/286242
dc.identifier.volume19en_US
dc.identifier.wosWOS:000447766200001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherCumhurıyet unıv tıp fak psıkıyatrı anabılım dalı, cumhurıyet unıv tıp fak psıkıyatrı abd, sıvas, 58140, turkeyen_US
dc.relation.ispartofAnadolu psıkıyatrı dergısı-anatolıan journal of psychıatryen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.subjectNeuroactıve steroıdsen_US
dc.subjectpanıc dısorderen_US
dc.subjectcerebrospınal-fluıden_US
dc.subjectmajor depressıonen_US
dc.subjectneurosteroıdsen_US
dc.subjectfluoxetıneen_US
dc.subjectıncreaseen_US
dc.subjectstressen_US
dc.subjectbraınen_US
dc.subjectpregnenoloneen_US
dc.titlePlasma allopregnanolone levels in drug-free, comorbidity-free obsessive-compulsive disorderen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: